Allows licensed pharmacists to initiate treatment for COVID-19, influenza, and pharyngitis caused by Group A streptococcal infection under certain.

This bill amends the education law to allow licensed pharmacists to initiate treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection, provided they follow a statewide protocol developed by the New York State Department of Health. The protocol includes guidelines on patient safety, record-keeping, referrals, and continuity of care. Pharmacists must report test results and treatments to the patient's designated physician, physician's assistant, or nurse practitioner.

Allows licensed pharmacists to initiate treatment for COVID-19, influenza, and pharyngitis caused by Group A streptococcal infection under certain.

This bill amends the education law to allow licensed pharmacists to initiate treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection, provided they follow a statewide protocol developed by the New York State Department of Health. The protocol includes guidelines on patient safety, record-keeping, referrals, and continuity of care. Pharmacists must report test results and treatments to the patient's designated physician, physician's assistant, or nurse practitioner.